Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Hearing On The Origins Of Covid-19 - Washington

Steven C. Quay, M.D., PH.D., Chief Executive Officer Atossa Therapeutics, Inc. and Former Faculty, Stanford University School of Medicine, appears before a Senate Committee on Homeland Security and Governmental Affairs hearing to examine origins of COVID-19, focusing on available evidence in the Dirksen Senate Office Building in Washington, DC, Tuesday, June 18, 2024. Photo by Rod Lamkey/CNP/ABACAPRESS.COM

E

Hearing On The Origins Of Covid-19 - Washington

Steven C. Quay, M.D., PH.D., Chief Executive Officer Atossa Therapeutics, Inc. and Former Faculty, Stanford University School of Medicine, appears before a Senate Committee on Homeland Security and Governmental Affairs hearing to examine origins of COVID-19, focusing on available evidence in the Dirksen Senate Office Building in Washington, DC, Tuesday, June 18, 2024. Photo by Rod Lamkey/CNP/ABACAPRESS.COM

E

Hearing On The Origins Of Covid-19 - Washington

Left to Right: Gregory D. Koblentz, PH.D., Associate Professor and Director, Biodefense Graduate Program, George Mason University, Robert F. Garry, PH.D., Professor and Associate Dean School of Medicine, Tulane University, Steven C. Quay, M.D., PH.D., Chief Executive Officer Atossa Therapeutics, Inc. and Former Faculty, Stanford University School of Medicine and Richard H. Ebright, PH.D., Board of Governors Professor of Chemistry and Chemical Biology and Laboratory Director, Waksman Institute of Microbiology, Rutgers University are sworn-in during a Senate Committee on Homeland Security and Governmental Affairs hearing to examine origins of COVID-19, focusing on available evidence in the Dirksen Senate Office Building in Washington, DC, Tuesday, June 18, 2024. Photo by Rod Lamkey/CNP/ABACAPRESS.COM

E

Hearing On The Origins Of Covid-19 - Washington

Steven C. Quay, M.D., PH.D., Chief Executive Officer Atossa Therapeutics, Inc. and Former Faculty, Stanford University School of Medicine, appears before a Senate Committee on Homeland Security and Governmental Affairs hearing to examine origins of COVID-19, focusing on available evidence in the Dirksen Senate Office Building in Washington, DC, Tuesday, June 18, 2024. Photo by Rod Lamkey/CNP/ABACAPRESS.COM

E

Hearing On The Origins Of Covid-19 - Washington

Steven C. Quay, M.D., PH.D., Chief Executive Officer Atossa Therapeutics, Inc. and Former Faculty, Stanford University School of Medicine, is sworn-in during a Senate Committee on Homeland Security and Governmental Affairs hearing to examine origins of COVID-19, focusing on available evidence in the Dirksen Senate Office Building in Washington, DC, Tuesday, June 18, 2024. Photo by Rod Lamkey/CNP/ABACAPRESS.COM

E

Illustration VistaGen Therapeutics

SUQIAN, CHINA - AUGUST 7, 2023 - Illustration VistaGen Therapeutics, August 8, 2023, Suqian, Jiangsu Province, China.

E

Illustration VistaGen Therapeutics

SUQIAN, CHINA - AUGUST 7, 2023 - Illustration VistaGen Therapeutics, August 8, 2023, Suqian, Jiangsu Province, China.

E

Illustration VistaGen Therapeutics

SUQIAN, CHINA - AUGUST 7, 2023 - Illustration VistaGen Therapeutics, August 8, 2023, Suqian, Jiangsu Province, China.

E

Senate Hearings - Washington

Christine Ann Miller, President and Chief Executive Officer of Melinta Therapeutics, testifies during a Senate Health, Education, Labor, and Pensions Subcommittee on Primary Health and Retirement Security hearing examining superbugs, Tuesday, July 11, 2023, in the Dirksen Senate Office Building in Washington, DC, USA. Photo by Julia Nikhinson/CNP/ABACAPRESS.COM

E

CHINA-SHANDONG-TENGZHOU-ANTI-DIABETES (CN)

(221117) -- BEIJING, Nov. 17, 2022 (Xinhua) -- Nursing practitioner Zhang Zhiping (R) measures a patient's blood sugar level at the Workers' Hospital of Tengzhou, east China's Shandong Province, Nov. 17, 2022. TO GO WITH "China Focus: Improved diagnostics and therapeutics delivery in diabetes fight" (Photo by Song Haicun/Xinhua)

E

Indonesia urges expanding global manufacturing, research hubs for future pandemic

STORY: Indonesia urges expanding global manufacturing, research hubs for future pandemic DATELINE: Aug. 23, 2022 LENGTH: 00:01:47 LOCATION: BALI, Indonesia CATEGORY: HEALTH SHOTLIST: 1. various of the meeting and the participants 2. SOUNDBITE (English): BUDI GUNADI SADIKIN, Indonesian Health Minister STORYLINE: Indonesia calls on members of G20 countries to expand global health manufacturing and research hubs as part of efforts to strengthen the global health architecture. Indonesian Health Minister Budi Gunadi Sadikin conveyed the message on Monday during the opening of the third G20 Health Working Group Meeting in Bali. SOUNDBITE (English): BUDI GUNADI SADIKIN, Indonesian Health Minister "I do hope that after this meeting, we can have a concrete agreement on how can we redistribute the global capacity for research and manufacturing, for therapeutics, diagnostic, and vaccines for the next pandemic. Whenever it happens, we are ready." The G20 host country emphasized that a pandemic can emerge anywhere.